BioSpecifics (BSTC) Reports Positive Top-Line Data from XIAFLEX Phase III in Peyronie's Disease
Go back to BioSpecifics (BSTC) Reports Positive Top-Line Data from XIAFLEX Phase III in Peyronie's Disease| Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) | Delayed: 36.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.47 | 52 Week High | $37.93 | |||
| Open | $1.87 | 52 Week Low | $17.10 | |||
| Day High | $36.47 | P/E | 16.35 | |||
| Day Low | $36.47 | EPS | $2.23 | |||
| Volume | 64,750 | |||||
| BioSpecifics Technologies Corp. (NASDAQ: BSTC) | Delayed: 88.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.53 | 52 Week High | $52.00 | |||
| Open | $752.95 | 52 Week Low | $30.70 | |||
| Day High | $88.53 | P/E | 132.13 | |||
| Day Low | $88.53 | EPS | $0.67 | |||
| Volume | 85 | |||||
